about
Increased efficacy of a dendritic cell-based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor.Identification of proteins derived from Listeria monocytogenes inducing human dendritic cell maturation.Identification of Toxoplasma gondii protein fractions induce immune response against melanoma in mice.T Cell Exhaustion in Glioblastoma: Intricacies of Immune Checkpoints.Listeria monocytogenes protein fraction induces dendritic cells maturation and T helper 1 immune responses.Efficacy and Safety of G2013 as a Novel Immunosuppressive Agent on Differentiation, Maturation and Function of Human Dendritic Cells.The Safety Property of β-D-Mannuronic Acid (M2000) as a Novel Immunosuppressive Agent on Differentiation, Maturation and Function of Human Dendritic Cells.Tumour regression induced by co-administration of MIP-3α and CpG in an experimental model of colon carcinoma.Lactobacillus crispatus strain SJ-3C-US induces human dendritic cells (DCs) maturation and confers an anti-inflammatory phenotype to DCs.Study of the tumor microenvironment during breast cancer progression.Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients.Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer.Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice.Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activityControl of brain tumor growth by reactivating myeloid cells with niacinThe Opposite Effects of DNA and Protein Components of Listeria Monocytogenes and Toxoplasma gondii on Immunologic Characteristics of Dendritic Cells
P50
Q38710158-10B98DA7-9A15-4FDB-810D-D4C694E7EF3EQ38793483-4AA72B97-CD52-4BB2-B059-1B158C31E33CQ38855600-90AA75D1-A7ED-4414-8247-DB97E53E72B3Q39037803-082D97CD-4217-43ED-873D-A56EDB8C4D5FQ39043263-FDCC3A5E-5AB8-4DDB-A30D-FE9AA5753DD0Q40234399-F6BAE7BE-5793-4D7A-9741-28AC39DDA5B6Q42101391-470FE685-ADA4-4EE2-B23F-6F2E9BF57C2CQ44828889-3E33C470-E881-4306-A75F-1F7B1B3A43D0Q46539797-2CE3365F-94EF-41CA-8B93-386ED969E714Q47159979-45ACE021-B605-44D9-9C6E-D99887C1E9EBQ50722110-A9E89B6E-2BB3-4EF5-97CA-E65FD3DFBFBAQ50975136-58C40C07-E10B-4843-A86D-BB9BC73E9B9BQ51589499-A58C2FE1-F54A-456D-AD6C-CEC8E76136B7Q52728329-0AA419A1-9534-46B5-B6DE-3B6FB8A7A18AQ57135138-39668582-9C66-471B-8B89-50CD368D5E1AQ90834312-F501905A-9567-4AE5-9A9A-A83F30D4AE57Q95477411-A2BBED25-C489-43E5-95FA-049D833FDE68
P50
description
researcher ORCID ID = 0000-0002-2393-2770
@en
wetenschapper
@nl
name
Reza Mirzaei
@ast
Reza Mirzaei
@en
Reza Mirzaei
@es
Reza Mirzaei
@nl
type
label
Reza Mirzaei
@ast
Reza Mirzaei
@en
Reza Mirzaei
@es
Reza Mirzaei
@nl
prefLabel
Reza Mirzaei
@ast
Reza Mirzaei
@en
Reza Mirzaei
@es
Reza Mirzaei
@nl
P1153
57200749662
P31
P496
0000-0002-2393-2770